Assessment of endometrial sampling as a predictor of final surgical pathology in endometrial cancer

British Journal of Cancer

Volumn 110, Issue 3, 2014, Pages 609-615

  Helpman, L ^a   Kupets, R ^b,c   Covens, A ^b,c   Saad, R S ^b,d   Khalifa, M A ^b,d   Ismiil, N ^b,d   Ghorab, Z ^b,d   Dube V ^b,d   Nofech Mozes, S ^b,d  

^a SHEBA MEDICAL CENTER   (Israel)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

endometrial biopsy; endometrial cancer; endometrial cancer staging; endometrial carcinoma grading; endometrial histology; endometrial sampling

Indexed keywords

ADULT; AGED; BIOPSY; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYSTERECTOMY; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY, SURGICAL; PREOPERATIVE CARE;

EID: 84893786639     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.766     Document Type: Article

References (52)

1. Aalders J, Abeler V, Kolstad P, Onsrud M (1980) Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients. Obstet Gynecol 56: 419-427.
2. Alhilli MM, Podratz KC, Dowdy SC, Bakkum-Gamez JN, Weaver AL, Mcgree ME, Kumar S, Keeney GL, Cliby WA, Mariani A (2012) Preoperative biopsy and intraoperative tumor diameter predict lymph node dissemination in endometrial cancer. Gynecol Oncol 128: 294-299.
3. Alhilli MM, Podratz KC, Dowdy SC, Bakkum-Gamez JN,Weaver AL, Mcgree ME, Kumar S, Keeney GL, Cliby WA, Mariani A (2013) Preoperative biopsy and intraoperative tumor diameter predict lymph node dissemination in endometrial cancer. Gynecol Oncol 128: 294-299.
4. Antonsen SL, Jensen LN, Loft A, Berthelsen AK, Costa J, Tabor A, Qvist I, Hansen MR, Fisker R, Andersen ES, Sperling L, Nielsen AL, Asmussen J, Hogdall E, Fago-Olsen CL, Christensen IJ, Nedergaard L, Jochumsen K, Hogdall C (2013) MRI, PET/CT and ultrasound in the preoperative staging of endometrial cancer-a multicenter prospective comparative study. Gynecol Oncol 128: 300-308.
5. Benedetti Panici P, Basile S, Maneschi F, Alberto Lissoni A, Signorelli M, Scambia G, Angioli R, Tateo S, Mangili G, Katsaros D, Garozzo G, Campagnutta E, Donadello N, Greggi S, Melpignano M, Raspagliesi F, Ragni N, Cormio G, Grassi R, Franchi M, Giannarelli D, Fossati R, Torri V, Amoroso M, Croce C, Mangioni C (2008) Systematic pelvic lymphadenectomy vs no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst 100: 1707-1716.
6. Bernardini MQ, May T, Khalifa MA, Bland AE, Nofech-Mozes S, Berchuck A, Covens A, Havrilesky L (2009) Evaluation of two management strategies for preoperative grade 1 endometrial cancer. Obstet Gynecol 114: 7-15.
7. Boren T, Lea J, Kehoe S, Miller DS, Richardson D (2012) Lymph node metastasis in endometrioid adenocarcinomas of the uterine corpus with occult cervical involvement. Gynecol Oncol 127: 43-46.
8. Briet JM, Hollema H, Reesink N, Aalders JG, Mourits MJ, Ten Hoor KA, Pras E, Boezen HM, Van Der Zee AG, Nijman HW (2005) Lymphvascular space involvement: an independent prognostic factor in endometrial cancer. Gynecol Oncol 96: 799-804.
9. Convery PA, Cantrell LA, Di Santo N, Broadwater G, Modesitt SC, Secord AA, Havrilesky LJ (2011) Retrospective review of an intraoperative algorithm to predict lymph node metastasis in low-grade endometrial adenocarcinoma. Gynecol Oncol 123: 65-70.
10. Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB (1987) Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer 60: 2035-2041.
11. Creutzberg CL, Van Putten WL, Koper PC, Lybeert ML, Jobsen JJ, Warlam-Rodenhuis CC, De Winter KA, Lutgens LC, Van Den Bergh AC, Van De Steen-Banasik E, Beerman H, Van Lent M (2000) Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet 355: 1404-1411.
12. Doering DL, Barnhill DR, Weiser EB, Burke TW, Woodward JE, Park RC (1989) Intraoperative evaluation of depth of myometrial invasion in stage I endometrial adenocarcinoma. Obstet Gynecol 74: 930-933.
13. Dowdy SC, Borah BJ, Bakkum-Gamez JN, Weaver AL, Mcgree ME, Haas LR, Keeney GL, Mariani A, Podratz KC (2012) Prospective assessment of survival, morbidity, and cost associated with lymphadenectomy in low-risk endometrial cancer. Gynecol Oncol 127: 5-10.
14. Fanning J, Tsukada Y, Piver MS (1990) Intraoperative frozen section diagnosis of depth of myometrial invasion in endometrial adenocarcinoma. Gynecol Oncol 37: 47-50.
15. Frumovitz M, Singh DK, Meyer L, Smith DH, Wertheim I, Resnik E, Bodurka DC (2004) Predictors of final histology in patients with endometrial cancer. Gynecol Oncol 95: 463-468.
16. Goff BA, Kato D, Schmidt RA, Ek M, Ferry JA, Muntz HG, Cain JM, Tamimi HK, Figge DC, Greer BE (1994) Uterine papillary serous carcinoma: patterns of metastatic spread. Gynecol Oncol 54: 264-268.
17. Hamilton CA, Cheung MK, Osann K, Chen L, Teng NN, Longacre TA, Powell MA, Hendrickson MR, Kapp DS, Chan JK (2006) Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers. Br J Cancer 94: 642-646.
18. Inoue Y, Obata K, Abe K, Ohmura G, Doh K, Yoshioka T, Hoshiai H, Noda K (1996) The prognostic significance of vascular invasion by endometrial carcinoma. Cancer 78: 1447-1451.
19. Kisu I, Banno K, Lin LY, Ueno A, Abe T, Kouyama K, Okuda S, Masugi Y, Umene K, Nogami Y, Tsuji K, Masuda K, Ueki A, Kobayashi Y, Yamagami W, Susumu N, Aoki D (2013) Preoperative and intraoperative assessment of myometrial invasion in endometrial cancer: comparison of magnetic resonance imaging and frozen sections. Acta Obstet Gynecol Scand 92: 525-535.
20. Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK (2009) Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 373: 125-136.
21. Koskas M, Bassot K, Graesslin O, Aristizabal P, Barranger E, Clavel-Chapelon F, Haddad B, Luton D, Darai E, Rouzier R (2013) Impact of lymphovascular space invasion on a nomogram for predicting lymph node metastasis in endometrial cancer. Gynecol Oncol 129: 292-297.
22. Kumar S, Medeiros F, Dowdy SC, Keeney GL, Bakkum-Gamez JN, Podratz KC, Cliby WA, Mariani A (2012) A prospective assessment of the reliability of frozen section to direct intraoperative decision making in endometrial cancer. Gynecol Oncol 127: 525-531.
23. Larson DM, Connor GP, Broste SK, Krawisz BR, Johnson KK (1996) Prognostic significance of gross myometrial invasion with endometrial cancer. Obstet Gynecol 88: 394-398.
24. Laufer J, Scasso S, Papadia A, Sosa C, Cirillo F, Raspagliesi F (2013) Association between tumor diameter and lymphovascular space invasion among women with early-stage endometrial cancer. Int J Gynaecol Obstet 123: 142-145.
25. Lee KB, Ki KD, Lee JM, Lee JK, Kim JW, Cho CH, Kim SM, Park SY, Jeong DH, Kim KT (2009) The risk of lymph node metastasis based on myometrial invasion and tumor grade in endometrioid uterine cancers: a multicenter, retrospective Korean study. Ann Surg Oncol 16: 2882-2887.
26. Leitao Jr MM, Kehoe S, Barakat RR, Alektiar K, Gattoc LP, Rabbitt C, Chi DS, Soslow RA, Abu-Rustum NR (2008) Accuracy of preoperative endometrial sampling diagnosis of FIGO grade 1 endometrial adenocarcinoma. Gynecol Oncol 111: 244-248.
27. Leitao Jr MM, Kehoe S, Barakat RR, Alektiar K, Gattoc LP, Rabbitt C, Chi DS, Soslow RA, Abu-Rustum NR (2009) Comparison of D&C and office endometrial biopsy accuracy in patients with FIGO grade 1 endometrial adenocarcinoma. Gynecol Oncol 113: 105-108.
28. Leitao Jr MM, Kehoe S, Barakat RR, Alektiar K, Rabbitt C, Chi DS, Soslow RA, Abu-Rustum NR (2010) Endometrial sampling diagnosis of FIGO grade 1 endometrial adenocarcinoma with a background of complex atypical hyperplasia and final hysterectomy pathology. Am J Obstet Gynecol 202: 278, e1-e6.
29. Maneschi F, Ceccacci I, Perugini A, Pane C, Simeone A, Manicone A (2012) Endometrial cancer: prognostic significance of risk classification based on pre-intraoperative findings. Arch Gynecol Obstet 285: 521-527.
30. Marcickiewicz J, Sundfeldt K (2011) Accuracy of intraoperative gross visual assessment of myometrial invasion in endometrial cancer. Acta Obstet Gynecol Scand 90: 846-851.
31. Mariani A, Dowdy SC, Cliby WA, Gostout BS, Jones MB, Wilson TO, Podratz KC (2008) Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol Oncol 109: 11-18.
32. Mariani A, Webb MJ, Keeney GL, Aletti G, Podratz KC (2002) Predictors of lymphatic failure in endometrial cancer. Gynecol Oncol 84: 437-442.
33. Mariani A, Webb MJ, Keeney GL, Haddock MG, Calori G, Podratz KC (2000) Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary? Am J Obstet Gynecol 182: 1506-1519.
34. Milam MR, Java J, Walker JL, Metzinger DS, Parker LP, Coleman RL. Gynecologic Oncology, G. (2012) Nodal metastasis risk in endometrioid endometrial cancer. Obstet Gynecol 119: 286-292.
35. Morrow CP, Bundy BN, Kurman RJ, Creasman WT, Heller P, Homesley HD, Graham JE (1991) Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol 40: 55-65.
36. Nemani D, Mitra N, Guo M, Lin L (2008) Assessing the effects of lymphadenectomy and radiation therapy in patients with uterine carcinosarcoma: a SEER analysis. Gynecol Oncol 111: 82-88.
37. Neubauer NL, Havrilesky LJ, Calingaert B, Bulusu A, Bernardini MQ, Fleming ND, Bland AE, Secord AA (2009) The role of lymphadenectomy in the management of preoperative grade 1 endometrial carcinoma. Gynecol Oncol 112: 511-516.
38. Nofech-Mozes S, Ackerman I, Ghorab Z, Ismiil N, Thomas G, Covens A, Khalifa MA (2008) Lymphovascular invasion is a significant predictor for distant recurrence in patients with early-stage endometrial endometrioid adenocarcinoma. Am J Clin Pathol 129: 912-917.
39. Nofech-Mozes S, Ismiil N, Dube V, Saad RS, Ghorab Z, Grin A, Ackerman I, Khalifa MA (2012) Interobserver agreement for endometrial cancer characteristics evaluated on biopsy material. Obstet Gynecol Int 2012: 414086.
40. Nout RA, Van De Poll-Franse LV, Lybeert ML, Warlam-Rodenhuis CC, Jobsen JJ, Mens JW, Lutgens LC, Pras B, Van Putten WL, Creutzberg CL (2011) Long-term outcome and quality of life of patients with endometrial carcinoma treated with or without pelvic radiotherapy in the post operative radiation therapy in endometrial carcinoma 1 (PORTEC-1) trial. J Clin Oncol 29: 1692-1700.
41. Petersen RW, Quinlivan JA, Casper GR, Nicklin JL (2000) Endometrial adenocarcinoma-presenting pathology is a poor guide to surgical management. Aust N Z J Obstet Gynaecol 40: 191-194.
42. Randall ME, Filiaci VL, Muss H, Spirtos NM, Mannel RS, Fowler J, Thigpen JT, Benda JA (2006) Randomized phase III trial of wholeabdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol 24: 36-44.
43. Savelli L, Testa AC, Mabrouk M, Zannoni L, Ludovisi M, Seracchioli R, Scambia G, De Iaco P (2012) A prospective blinded comparison of the accuracy of transvaginal sonography and frozen section in the assessment of myometrial invasion in endometrial cancer. Gynecol Oncol 124: 549-552.
44. Schink JC, Lurain JR, Wallemark CB, Chmiel JS (1987) Tumor size in endometrial cancer: a prognostic factor for lymph node metastasis. Obstet Gynecol 70: 216-219.
45. Scholten AN, Smit VT, Beerman H, Van Putten WL, Creutzberg CL (2004) Prognostic significance and interobserver variability of histologic grading systems for endometrial carcinoma. Cancer 100: 764-772.
46. Shim JU, Rose PG, Reale FR, Soto H, Tak WK, Hunter RE (1992) Accuracy of frozen-section diagnosis at surgery in clinical stage I and II endometrial carcinoma. Am J Obstet Gynecol 166: 1335-1338.
47. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62: 10-29.
48. Silverberg SG, Major FJ, Blessing JA, Fetter B, Askin FB, Liao SY, Miller A (1990) Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus. A Gynecologic Oncology Group pathologic study of 203 cases. Int J Gynecol Pathol 9: 1-19.
49. Temkin SM, Hellmann M, Lee YC, Abulafia O (2007) Early-stage carcinosarcoma of the uterus: the significance of lymph node count. Int J Gynecol Cancer 17: 215-219.
50. Thomas M, Mariani A, Wright JD, Madarek EO, Powell MA, Mutch DG, Podratz KC, Dowdy SC (2008) Surgical management and adjuvant therapy for patients with uterine clear cell carcinoma: a multi-institutional review. Gynecol Oncol 108: 293-297.
51. Traen K, Holund B, Mogensen O (2007) Accuracy of preoperative tumor grade and intraoperative gross examination of myometrial invasion in patients with endometrial cancer. Acta Obstet Gynecol Scand 86: 739-741.
52. Wu LM, Xu JR, Gu HY, Hua J, Haacke EM, Hu J (2013) Predictive value of T2-weighted imaging and contrast-enhanced MR imaging in assessing myometrial invasion in endometrial cancer: a pooled analysis of prospective studies. Eur Radiol 23: 435-449.